A device for insertion into an airway of a subject, the device including: an arm defining a distal end and a proximal end, the arm including: an elongate handle portion at the proximal end, the handle portion extending substantially towards the distal end, and an offset portion located between the distal end and the handle portion, the offset portion being offset dorsally relative to the handle portion and the distal end; and a tip at the distal end of the arm, wherein the arm is configured to allow a user to hold the handle portion outside of a mouth of the subject and move the handle portion to move the tip through the mouth and pharynx of the subject to thereby position the tip proximate to a larynx of the subject.

An airway device includes an outertube and a scope channel partially enclosed by the outertube. An intraluminal space in the outertube, not occupied by the scope channel, provides a passageway for air flow to the patient. An esophageal cuff is disposed distally on the scope channel. When inflated, the esophageal cuff secures the airway device in the proximal esophagus of the patient and helps to prevent gastric reflux by mechanically blocking gastric content from entering into the larynx. An inflatable bladder is attached at an anterior surface of the scope channel between the esophageal cuff and a distal opening of the outertube. When inflated, the bladder forms a tubular ring that pushes against the epiglottis and/or other soft tissue towards a wall of the hypopharynx to produce an unhindered air passage into the patient's trachea.

Described here are systems and methods for delivering an active agent to target tissues of the ear, nose, or throat using an expandable member having drug crystals layered thereon, and methods for manufacturing such systems. The expandable member can be delivered to the target tissues in a low-profile configuration and expanded to contact and/or dilate surrounding tissue. Expansion of the expandable member transfers the drug crystals to the target tissues, which then act as an in situ depot that enables maintenance of a therapeutic level of an active agent for a desired time period after removal of the expandable member. Multiple expansions of a single expandable member can be employed during treatment. For example, the systems and methods can be useful when it is desired to treat multiple paranasal sinuses with a single expandable member.

Endotracheal intubation support instrument comprises: a main body section having flexibility; a handle section and a blade section extending from both sides of the main body section respectively; and a U-shaped groove running through the main body section from the handle section to the blade section and allowing a flexible tube of a bronchial fiber to come in and out freely. The blade section comprises: a flap for subsuming all or a part of a larynx of a patient; and a lifting body having, on each bank of the U-shape groove, a first protruding portion allowed to contact with a peripheral portion of an epiglottis of the patient and a second protruding portion provided next to a main body section side of the first protruding portion and allowed to contact with a peripheral portion of a glossal root of the patient.

A system comprising a handpiece and drive system configured to removably couple to a proximal end of a housing. A scalpet assembly is configured to removeably couple to the housing, and includes a scalpet array comprising at least one scalpet configured for rotation. The scalpet array is configured to harvest dermal plugs via fractional resection. A collection chamber is configured to collect the dermal plugs, and to house formation of an injectable filler by mincing the dermal plugs, and mixing the dermal plugs with a carrier. The injectable filler is configured for bulk fill. The collection chamber includes a loading port, and a cannular syringe is configured to mate with the loading port to receive the injectable filler, and to deliver the injectable filler for the bulk fill.

An airway device to be inserted into a patient's throat and to be function as a supraglottic airway device during a positive pressure ventilation and spontaneous ventilation that includes an air tube, an air sac, a tongue lifting means, a pulling unit and a drainage systems. The pulling unit will be pulled by an operator's hand to cause the tongue lifting means upward movement to open up the air sac and lift up the tongue base. The air tube lumen and the air sac are configured to have inflow airflow be divided and follow specific route therefore to deliver the focused airflow to vocal cords opening, and also to let inspired airflow enter desired area of the air sac to expand the air sac to form seals with surrounding tissue. During expiration, the pressure will be relieved. Different design of the drainage system can be configured to drained fluid from upper esophagus or from posterior pharyngeal wall.

The hiccup relieving apparatus includes a tube with a first end having a mouthpiece, a second end for immersion in water or other potable liquid in a container, and an obstruction in the tube between the first end and the second end. The obstruction requires an adult user, using the mouthpiece, to produce a threshold suction of at least 20 cm of water before water can flow from the water in the water container, through the tube, through the mouthpiece, and to the user. The obstruction can take the form of a threshold valve in the tube, a sized orifice in the immersed end of the tube, or a wad of cellulosic material in the tube.

Described here are systems and methods for delivering an active agent to target tissues of the ear, nose, or throat using a drug delivery platform having the therapeutic drug embedded as part of the drug delivery platform. The drug delivery platform is implanted into a target tissue, and the active agent elutes out of the body of the drug delivery platform for a target period of time, delivering a therapeutic dose of the drug for that period of time. The duration of therapy for an implant into a sinus tissue can be from 3 to 12 months, or longer, thereby providing relief for the full duration of an allergy season. Moreover, the duration of therapy can provide relief to individuals with chronic paranasal sinus condition symptoms for a period of time longer than presently available therapies, thus allowing for only semi-annual or annual applications of the therapy.

The Invention of a method of Closing an Orifice located right behind the Epiglottis under the vocal cords unlocks the keys of Immune System and adjusts the Endocrine system. This Orifice is responsible of letting Saliva streaming abnormally into capillaries to imbue them with extra water and inhibiting digested nutrients of Plasma to enter capillaries due to deregulation of Starling Forces. A phenomenon that damages capillaries membranes by creating perforations and reducing the functioning capacity of the lymphatic system and T, B and NK Cells, responsible of enhancing the Immune System. Closing this Orifice will drain out Extra water (Saliva) of capillaries and regulate Starling forces to enable nutrients to enter bloodstream and to increase cells Metabolism, regulate hormones secretion, enable the maturation of NK cells to kill cancers, regulate blood sugar, regulate blood pressure, repair brain's neurons and reproduce new cells to replace defected ones.

Described here are systems and methods for delivering an active agent to target tissues of the ear, nose, or throat using an expandable member having drug crystals layered thereon, and methods for manufacturing such systems. The expandable member can be delivered to the target tissues in a low-profile configuration and expanded to contact and/or dilate surrounding tissue. Expansion of the expandable member transfers the drug crystals to the target tissues, which then act as an in situ depot that enables maintenance of a therapeutic level of an active agent for a desired time period after removal of the expandable member. Multiple expansions of a single expandable member can be employed during treatment. For example, the systems and methods can be useful when it is desired to treat multiple paranasal sinuses with a single expandable member.